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Iron handling and gene expression of the divalent metal trans-
porter, DMT1, in the kidney of the anemic Belgrade (b) rat.
Background. We have previously shown that the rat kidney
reabsorbs metabolically significant amounts of iron and that it
expresses the divalent metal transporter 1, DMT1. The Bel-
grade (b) rat carries a mutation in DMT1 gene, which causes
hypochromic, microcytic anemia due to impaired intestinal iron
absorption and transport of iron out of the transferrin cycle
endosome. In the duodenum of b/b rats, expression of DMT1
mRNA and protein is increased, suggesting a feedback reg-
ulation by iron stores. The aim of this study was to investi-
gate iron handling and DMT1 expression in the kidneys of
Belgrade rats.
Methods. Animals were maintained for 3 weeks on a syn-
thetic diet containing 185 mg/kg iron (FeSO4), after which
functional and molecular parameters were analyzed in male
heterozygous (/b) and homozygous (b/b) rats (N  4 to 6
for each group).
Results. Serum iron concentration was significantly higher
in b/b compared to /b rats while urinary iron excretion rates
were unchanged in b/b compared to/b rats. Northern analysis
using a rat DMT1 probe showed comparable mRNA levels
between /b and b/b animals. Western analysis and immuno-
fluorescence microscopy performed using a polyclonal anti-
body against rat DMT1 showed that DMT1-specific immunore-
activity was almost absent in the kidneys of b/b rats compared
to that seen in /b animals.
Conclusion. Our results indicate that the G185R mutation
of DMT1 causes protein instability in the kidneys of b/b rats.
Given that /b and b/b rats excrete comparable amounts of
iron, the lack of DMT1 protein is compensated by an alterna-
tive, yet to be identified, mechanism.
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The Belgrade (b) rat and the equivalent murine model,
mk mouse, carry a nonconservative glycine-to-arginine
substitution, G185R, in the putative TM4 of the divalent
metal transporter, DMT1 (also DCT1, Nramp2, Slc11-
A2) [1–3] The phenotype is a microcytic anemia, which is
inherited as an autosomal-recessive trait. b/b rats exhibit
defective iron uptake by the gastrointestinal tract and
deficient iron transport in erythroid cell precursors de-
spite increased total iron binding capacity [4]. Bone mar-
row transplantation studies demonstrated that mk/mk
mice have a hematopoietic defect in addition to an intes-
tinal defect in iron metabolism [5]. In b/b rats, sidero-
blasts are absent from the bone marrow and serum iron
is also elevated, although no iron deposits can be found
in these animals [6]. In b/b rats, transport of iron out of
the endosome to the cytoplasm as part of the transferrin
cycle is impaired [7]. In reticulocytes, iron acquisition
and hemoglobin synthesis are reduced [8, 9]. Transport
alterations were also seen with the nontransferrin-bound
iron [10, 11], which suggested that the defect was not
the release from transferrin, but in an iron transporter
or in a protein that regulates a transporter. Subsequent
studies demonstrated that the common pathway is
DMT1, which provides the actual iron transfer across
the plasma membrane [12].
Functionally, the G185R mutation in DMT1 causes
diminished iron transport into developing erythroid cells
[1, 7, 9]. In vitro studies using HEK293 cells overexpress-
ing wild-type and mutated DMT1 have shown that the
b allele encodes a protein with little or no activity in
iron uptake assays [12]. In the mouse, Northern blot
analysis on duodenal samples indicates that mk/mk ani-
mals exhibit a dramatic increase in DMT1 mRNA levels
compared to /mk mice [13]. This increase in mRNA
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expression is paralleled by a concomitant increase in
DMT1 protein expression in the duodenum [13], but not
in the kidneys of these animals [14]. Immunohistochemi-
cal analysis shows that, in contrast to normal mouse
enterocytes from mice kept on an iron-deprived diet,
little or no DMT1 expression can be seen at the apical
membrane in mk/mk mice, indicating that the G185R
mutation in DMT1 affects the membrane targeting of
the protein in mk/mk enterocytes and that, in an attempt
to compensate for the defective protein, DMT1 is up-
regulated at both mRNA and protein level [13]. Interest-
ingly, the renal expression of DMT1 is drastically de-
creased compared with that seen in /mk animals [14].
The authors suggested that these changes are suggestive
of a feedback regulation of DMT1 expression by iron
stores in the duodenum, but not in the kidney.
The phenotype of the Belgrade defect indicates that
the anemia in rodents is often fatal unless more iron is
made available, by either increasing dietary iron or by
direct iron injections [4, 15]. However, direct iron injec-
tions cannot fully correct the defect associated with the
b/b phenotype [4], suggesting that organs other than the
gastrointestinal tract are also affected by this mutation,
thereby contributing to total body iron homeostasis.
Recently, we have demonstrated that a metabolically
significant amount of iron is filtered at the glomerulus
and the majority is reabsorbed along the nephron [16].
We have also provided molecular evidence that DMT1
mRNA and protein are expressed along nephron sites
where iron reabsorption takes place [17]. The described
distribution of DMT1 protein is consistent with a role
for DMT1 in apical iron entry by the distal nephron while
in the proximal tubule DMT1 is potentially involved in
the transport of iron out of the endocytic pathway.
The aim of this study was to investigate the conse-
quences of the lack of DMT1 protein on renal handling
of iron and other electrolytes and to examine the expres-
sion of DMT1 in the kidneys of Belgrade rats. Three
approaches were taken. First, a multielement analysis
using inductively coupled plasma mass spectrometry was
performed on urine and plasma samples collected from
/b and b/b rats. Subsequently, the renal b/b phenotype
was compared to that of/b kidneys by histologic exami-
nations. Finally, intrarenal DMT1 mRNA and protein
distributions were examined by Northern analysis, semi-
quantitative immunoblotting, and immunofluorescence
microscopy. Here, we report that the G185R mutation
at DMT1 produces profound structural changes and re-
sults in the lack of detectable mature DMT1 protein in
the kidneys of b/b rats, and that mechanisms other than
DMT1 must be responsible for iron reabsorption by the
rat kidney.
METHODS
Breeding and maintenance of b/b rats
All experiments were performed within guidelines set
down in the United Kingdom’s Animals (Scientific Pro-
cedures) Act 1986. Anemic Belgrade/b rats were bred
from stock obtained from Dr Michael Garrick (SUNY,
Buffalo, NY, USA). Animals were descendants of the
original Belgrade colony, which has previously been
backcrossed for 10 generations onto a Harlan Sprague-
Dawley Wistar background [4]. These animals were sub-
sequently maintained as a closed colony in the Biological
Sciences Unit (University of Manchester, Manchester,
UK) by breeding homozygous b/b males to heterozygous
/b females. The progeny were visually discriminated
given the paler appearance and the reduced size of b/b
vs. /b rats.
Experimental animals
b/b rats inherit severe hypochromic, microcytic anemia
as an autosomal-recessive trait [6]. Garrick et al [4] have
shown dietary iron supplementation to improve hus-
bandry without altering the underlying defect. Prelimi-
nary experiments showed that feeding /b rats the iron-
supplemented diet described by Garrick et al [4] does
not produce histologic or molecular alterations (assessed
by hematoxylin-eosin staining and Western blotting, re-
spectively) compared to /b rats fed a normal iron-con-
taining diet (not shown). We have also observed no mor-
phologic changes in kidney structure in normal rats
maintained on this diet and in /b control rats fed the
iron-supplemented diet. Altogether our preliminary ob-
servations strongly suggested that the b/b renal pheno-
type is due to the b/b genotype rather than to the small
increase in dietary iron. Hence, to ensure that our obser-
vations were due to the DMT1 mutation rather than to
the associated anemia, age-matched (days) male /b
(184.5  8.3; N  4) and b/b (136.0  3.0; N  4) rats
were maintained for 3 weeks on an iron-supplemented
diet produced by Special Diet Services (Whitman, Essex,
UK) and were given deionized water ad libitum. After
this period, animals were individually housed in Home
Office–approved metabolism cages for 8 days. For the
first 5 days of the experiment (an acclimatization period),
food and water were changed daily but no data collection
was made. The experimental period was started on day
6 and continued through days 7 and 8 of the experiment.
Body weight and food and water intake were measured.
There were also 24-hour collections of feces and urine.
Data for days 6 to 8 were averaged to give a 24-hour
intake or output value for each animal. Samples were
stored in polypropylene vials and kept at 20C prior
to analysis.
Upon completion of the experiment, anesthesia was
induced with Inactin (5-ethyl-5(1-methyl-propyl)-2-thio-
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barbiturate) (Sigma RBI, Poole, Dorset, UK) at a dose
of 100 mg · kg1 intraperitoneally. A large terminal blood
sample was extracted from the descending aorta of the
animal using a 21 G needle attached to a short length
of portex polypropylene catheter. We have previously
noted that blood samples collected from the b/b rats
were more prone to hemolysis than those collected from
/b animals. To prevent this, blood samples were col-
lected directly into heparinized vials without any applica-
tion of suction. Upon completion of the collection, the
left and right kidneys were removed and snap-frozen in
liquid nitrogen for Northern and Western analyses, for
histologic examination, and for immunofluorescence mi-
croscopy (see below). Hemolysis was detected by assay-
ing for serum hemoglobin using a kit from Sigma (Poole,
Dorset, UK).
Iron concentration in the serum, urine, feces, and food
was measured using inductively coupled plasma mass
spectrometry (ICP-MS) (Hewlett Packard 4500, Stock-
port, UK). Food and feces were acid-digested using con-
centrated nitric acid (HNO3). Food/fecal samples were
weighed and then placed into an oven at 90C and desic-
cated. Approximately 0.2 g of desiccated sample was
placed into a loosely capped vial containing 10 mL of
18 N HNO3 and warmed to 90C for 24 hours to dissolve
the sample into solution. The cap was removed and the
oven temperature reduced to 58C to drive off the acid.
Once the acid had completely evaporated, the sample
was resuspended in 5 mL of 2 N HNO3. Samples were
measured by ICP-MS using 2 N HNO3 as a blank. Urine
samples were diluted 1:5 with tetramethylammonium hy-
droxide (TMA-OH) and measured by ICP-MS using
TMA-OH as a blank. Urine osmolality was measured on
the day of the experiment using a cryoscopic osmometer
(Roebling Camlab, Cambridge, UK).
Serum iron concentration was measured by flame
atomic absorption spectrophotometry (FAAS) (Perkin
Elmer 3100, Braknell, UK) as described previously [16].
Serum creatinine concentrations were determined using
Sigma Diagnostics Creatinine kit according to the manu-
facturers’ instructions. Urine pH was measured after col-
lecting 250 L samples directly from the animals’ blad-
ders and values were determined using a Beckman pH
meter (High Wycombe, UK). For measurements of
blood pH, animal procedures were reviewed and ap-
proved by the State University of New York at Buffalo
Institutional Animal Care and Use Committee. Three
b/b and three /b male rats, all 9 months old, were
anesthetized with halothane (Sigma-Aldrich, St. Louis,
MO, USA). Blood was obtained by retro-orbital sinus
puncture and was collected in heparinized microhemato-
crit capillary tubes. The tubes were sealed at both ends
with Critoseal sealing clay and placed on ice. Blood pH
was measured for duplicate samples at 37C using a Radi-
ometer ABL5 Blood Gas System (London Scientific,
London, UK). Instrument performance was verified by
using Bio-Rad Blood Gas Controls: level 1, acidosis, 6.80
(range 6.80 to 6.830); level 2, normal, 7.39 (range 7.38
to 7.42); and level 3, alkalosis, 7.61 (range 7.58 to 7.64)
(Bio-Rad, Anaheim, CA, USA).
RNA extraction and Northern analysis
At the end of the metabolic cage studies, adult, male
/b and b/b rats were killed, the kidneys removed and
snap-frozen using liquid N2. Duodenum tissue scrapes
from heterozygous or homozygous Belgrade rats were
used as a positive control for transcript up-regulation
[18]. Total RNA was isolated by the guanidine isothyocy-
anate method [19] using cesium-trifluoroacetic acid (Life
Technologies, Paisley, UK) as described previously [20].
Total RNA (15 g/lane) was separated in a 1% agarose
gel in the presence of 2.2 mol/L formaldehyde and trans-
ferred to Hybond-N filters (Amersham Pharmacia Bio-
tech, Little Chalfont, UK). Filters were probed using a
32P-labeled cDNA probe (17) containing nucleotides 85-
1600 of rat DMT1 (Genbank accession number AF02-
9757). After overnight hybridization at 42C in a buffer
containing 7% sodium dodecyl sulfate (SDS), 0.5 mol/L
NaHPO4 (pH 7.2), 1 mmol/L ethylenediaminetetraacetic
acid (EDTA), 50 mmol/L bovine serum albumin (BSA),
supplemented with denatured salmon sperm DNA (100
g/mL hybridization solution, Life Technologies), filters
were washed twice with 5  standars sodium citrate
(SSC), 0.1% SDS at 48C for 15 minutes, followed by
two washes in 0.1  SSC, 0.1% SDS at 60C for 15
minutes [20]. Autoradiography was performed at80C
using Biomax MS film (Kodak Biomax MS, Hemel
Hempstead, UK). To control for equal loading of RNA,
membranes were subsequently probed with a 32P-labeled
rat 	-actin cDNA probe (Genbank accession number
V01217).
Preparation of microsomal membrane fraction
and Western analysis
Alternative splicing of DMT1 generates two tran-
scripts that differ in the 3-end of the molecule [2, 21].
One of these contains an iron response element (IRE)
element in its 3-UTR. We have previously generated,
affinity-purified, and characterized an antiserum against
corresponding amino acid 1-21 of rat DMT1, (Sigma
Genosys, Cambridge, UK), which recognizes both IRE
and NIRE (non-IRE) isoforms of the protein. Our anti-
serum detects peptide/protectable immunoreactive spe-
cies of 60 to 90 kD in microsomal membrane fractions
from rat kidney [17].
Aliquots of microsomal membrane fraction containing
30 g of protein prepared as described elsewhere [17]
were incubated for 5 minutes at room temperature and
separated on an 8% SDS-polyacrylamide gel electropho-
resis (PAGE). To reduce between-group variability, kid-
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neys were processed in groups of two, one from each
experimental condition (i.e.,/b and b/b). Proteins were
transferred to BioTrace nitrocellulose membrane (Pall
Gelman Sciences, Northampton, UK) and the mem-
branes were incubated for 1 hour at room temperature
in the affinity-purified anti-DMT1 antiserum [17]. The
membranes were washed with several changes of Tris-
buffered saline with 20% Tween (TBST) [17], then incu-
bated for 1 hour at room temperature in goat antirabbit
IgG conjugated to horseradish peroxidase (Dako, Ltd.,
Ely, UK) diluted 1:5000 in TBST. A further washing step
was followed by visualization of the signal by enhanced
chemiluminescence (ECL Plus) (Amersham Pharmacia
Biotech, Little Chalfont, UK) according to the manufac-
turer’s protocol. Experiments were repeated in triplicate.
Protein concentration was determined using the Brad-
ford method (Bio-Rad Laboratories, Ltd., Hertfordshire,
UK). The protein equivalency of sample loading volumes
was demonstrated by staining of a SDS-PAGE gel with
Coomassie blue (not shown). Membranes incubated in
the absence of the primary antibody or with antiserum
preabsorbed with an excess of the immunizing peptide
served as negative controls.
Histology and immunofluorescence microscopy
To study DMT1 intrarenal distribution in/b and b/b
rats (four to six for each group) animals were anesthe-
tized with Inactin (Sigma RBI) at a dose of 100 to 110
mg/kg intraperitoneally. Perfusion was carried out as
described elsewhere [17] and 4 m thick cryosections
were cut using a Leica CM3050 cryostat (Leica Instru-
ments GmbH, Nussloch, Germany), thaw-mounted onto
Superfrost Plus slides (BDH, Poole, Dorset, UK) and
kept at –20C until used. For histologic examination,
slides were thawed, dipped into Meyer’s hemalum (BDH,
Poole, Dorset, UK), dehydrated through ethanol series,
and mounted using Eukitt (O Kindler GmbH & Co.,
Freiburg, Germany). DMT1 immunodetection was per-
formed as previously described using RA2719 affinity-
purified anti-DMT1 polyclonal antiserum [17]. Second-
ary antibody was goat antirabbit Alexa 594 (Molecular
Probes, Inc., Eugene, OR, USA) diluted into phosphate-
buffered saline (PBS) containing 5% normal goat serum
and 1% BSA. Intrarenal distribution of DMT1 and
aquaporin 1 (AQP1) or DMT1 and aquaporin 2 (AQP2)
was assessed on serial cryostat sections from animals
perfusion-fixed as described above. Both AQP1 and
AQP2 antisera (rabbit antirat) were obtained from
Alpha Diagnostic International, Inc. (Mile Elm, UK)
After rinsing with PBS, the sections were mounted using
Dako-GlycergelTM (Dako, Ltd., High Wycombe Bucks,
UK) added with 2.5% 1,4-diazabicyclo-[2.2.2]octane
(DABCO) (Sigma). Negative controls were carried out
by preincubating the DMT1 antiserum with an excess of
antigenic peptide and by omitting the primary anti-
bodies.
Slides were viewed using a Zeiss Axioplan 2 micro-
scope with 2.5-63 objectives. Images were acquired
using a Hamamatsu digital camera and processed using
the software package KS300, version 3.0 (Carl Zeiss,
Ltd., Welwyn Garden City, UK).
Iron deposits in rat kidney sections were visualized by
russian blue staining using the Accustain Iron Stain Kit
(Sigma Diagnostics, St. Louis, MO, USA) following
manufacturer’s instructions.
Statistical analysis
For measurements of serum, urine, and fecal iron con-
centration, statistical significance was assessed using sin-
gle-factor analysis of variance (ANOVA). Bonferroni’s
multiple comparison post hoc test was used to indicate
significant differences between groups. Values for ion
intakes and outputs are in mol/day1 · 100 g body
weight1 unless otherwise noted. For the semiquantita-
tive immunoblotting, one-way ANOVA with Dunnett’s
post-hoc test was used to compare differences between
/b and b/b rats [22]. Data are expressed as means /
SEM throughout the text, where N number of animals
unless otherwise stated. Significance was accepted at P

0.05. Statistical significance for serum creatinine concen-
trations of b/b and /b animals was calculated using a
Student t test. For measurements of blood pH, data were
analyzed on an AT-compatible computer using the pro-
gram STATA (Stata Corporation, College Station, TX,
USA). Both ANOVA and t test were performed, taking
P  0.05 to be significant.
RESULTS
Functional observations
Food and water intake and urine output. Data col-
lected for the intake of food indicate that b/b rats ate
significantly more than heterozygous /b rats (11.57 
0.26 g/day1 · 100 g body weight1 vs. 9.44 0.36 g/day1 ·
100 g body weight1; N  4; P 
 0.05; ANOVA). Mean
body weights of the two groups were also significantly
different [200  4.2 g (/b) and 150  0.9 g (b/b); N 
4; P 
 0.05; ANOVA].
Water intakes were 11.95  0.629 mL/day1 · 100 g
body weight1 and 14.77  0.81 mL/day1 · 100 g body
weight1 for /b and b/b rats, respectively (N  4; NS).
Measurements of urinary outputs indicate that/b and
b/b rats voided comparable amounts of urine (3.427 
0.53 mL/day1 · 100 g body weight1 vs. 3.426  0.47
mL/day1 · 100 g body weight1; N  4; NS). Urinary
osmotic outputs were 3.05  0.22 mOsm/day1 · 100 g
body weight1 and 3.25  0.28 mOsm/day1 · 100 g body
weight1 for /b and b/b rats, respectively (N  4; NS).
Urinary outputs of individual ions are detailed in Fig-
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Fig. 1. Food, serum, fecal, and urinary iron levels in /b and b/b rats.
The figure summarizes iron levels in the food, blood, feces, and urine
of /b and b/b rats kept for 3 weeks on an iron-supplemented diet.
This diet has previously been shown to ameliorate the severe anemia
without masking the underlying defect [3]. Serum iron levels were
significantly elevated in b/b compared to /b rats (P 
 0.05; N  4).
Fecal excretion and food intake were significantly higher in b/b rats
compared to /b rats (P 
 0.05; N  4). Urinary iron excretion was
no different between /b and b/b rats. Hemoglobin levels were low
and no different in the three experimental groups (not shown), sugges-
tive of no sample hemolysis. Values for ion intakes and outputs are in
mol1/day1 · 100 g body weight1 unless otherwise stated.
ures 1 and 2. The figures show that, for the majority of
ions tested (iron, sodium, potassium, magnesium, zinc,
and copper), the ion outputs were comparable in /b
and b/b rats (N  4; NS). The only exception to this
observation was calcium, for which b/b rats exhibited
marked hypercalciuria compared to /b (N  4; P 

0.05).
Individual ion intake, serum levels, and fecal output.
Electrolytes intake, serum levels, and fecal outputs for
/b and b/b rats are presented in Table 1. The table
shows that serum K was decreased, while serum Mg2
concentration was increased in b/b compared to/b rats.
The general trend is that fecal excretion of all ions is
increased in b/b compared with /b rats. This mirrors
food intake, which is also increased in b/b compared
with /b rats. Serum electrolyte levels do not differ be-
tween the two experimental groups. The only exception
is K, whose concentration was significantly reduced in
b/b compared with /b animals. With respect to iron,
b/b rats showed a substantial increase in the amount
of iron excreted in the feces compared to /b animals
(69.11  8.05 mol/L · day1 · 100 g body weight1 vs.
52.42  2.01 mol/L · day1 · 100 g body weight1) (N 
4; P 
 0.05) (see Fig. 1).
Fig. 2. Urinary electrolyte outputs in /b and b/b rats. Urines were
collected as above described and detection of electrolyte concentration
measured by inductively coupled plasma mass spectrometry (ICP-MS).
All data are mean  SEM (N  4 for each experimental condition)
and are expressed in mol/day1 · 100 g body weight1. Statistical
significance was tested using analysis of variance (ANOVA) (P
 0.05).
*b/b vs. /b. Solid bars, /b. Hatched bars, b/b.
Table 1. Electrolytes intake, serum levels, and fecal outputs
in the anemic Belgrade rat
Ion I/S/O /b b/b N P value
Na Food 1283.5147.47 1574.7934.63 4 
0.001
Serum 146.751.11 144.660.46 4 NS
Feces 33.994.07 36.553.50 4 NS
K Food 1265.2547.27 1552.4434.15 4 
0.001
Serum 4.820.18 3.580.11 4 
0.001
Feces 26.831.70 40.165.81 4 
0.05
Ca2 Food 1914.7771.10 2341.6450.10 4 
0.001
Serum 2.340.06 2.530.03 4 NS
Feces 883.9945.97 1089.69119.00 4 NS
Mg2 Food 357.3513.87 441.8610.45 4 
0.001
Serum 0.960.01 1.290.05 4 
0.01
Feces 259.7924.96 304.5929.03 4 NS
Zn2 Food 12.860.49 15.750.33 4 
0.001
Serum 21.520.47 23.220.38 4 NS
Feces 8.320.42 10.330.85 4 NS
Cu2 Food 2194.7381.80 2682.4057.22 4 
0.001
Serum 11.730.47 11.920.14 4 NS
Feces 1351.80191.2 1613.8438.44 4 NS
Mn2 Food 15,865.33755.71 19998579.85 4 
0.005
Serum 80.048.11 85.192.48 4 NS
Feces 11,673.84488.93 16,390.631490.50 4 
0.05
Ni2 Food 34.831.25 42.470.87 4 
0.005
Serum 29.101.53 37.572.49 4 
0.05
Feces 32.612.08 41.093.07 4 NS
Serum concentrations, mmol/L/day · 100 g body weight1 (Na, K, Ca2, and
Mg2); mol/L/day · 100 g body weight1 (Zn2, Cu2, and Mn2); nmol/L/day ·
100 g body weight1 (Ni2); food intake and fecal output, nmol/L/day · 100 g
body weight1 (Cu2 and Ni2). I/S/O is intake/serum levels/output.
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Fig. 3. Histologic examination of kidneys from anemic Belgrade rats.
Micrographs of hematoxylin-eosin (H&E) kidney paraformaldehyde-
fixed 4 m cryosections from /b (A and C ) and Belgrade (b/b, B and
D ) rats. (A) /b kidneys show clear junctions between the cortex and
outer medulla and between the outer and inner medulla (indicated by
block arrows). (B) b/b rats show a clear outer medulla/inner medulla
junction (block arrow) but the cortical/outer medullary junction is unde-
fined. Belgrade rat kidneys also exhibit projection of medullary epithe-
lium into the cortical region (arrow head) and the presence of dilated
spaces in the cortex (arrows). (C) H&E stained /b kidneys show
glomeruli (g) and cortical tubule structures (t). (D) Belgrade rat kidneys
show increased cellularity in glomeruli (g) and enhanced granularity in
the cells of the tubules (t). (A and B) magnification 2.5; (C and D)
magnification 20. Bar  10 m.
Other parameters
There was no indication of proteinuria in either experi-
mental group (N  6 for each condition). Urinary and
blood pH were normal and not statistically different be-
tween /b and b/b rats [urine pH values, 6.08  0.054
vs. 6.2  0.09; plasma pH values, 7.4  0.031 vs. 7.34 
0.004, /b vs. b/b, respectively, N  6, NS by both t test
and ANOVA). Plasma creatinine values were also not
statistically different between/b and b/b rats (102.52
3.61 mol/L1 vs. 98.47  11.51 mol/L1, respectively,
N  4, NS).
Histologic observations
Hematoxylin-eosin and iron deposits staining. Low
magnification micrographs of hematoxylin-eosin staining
of paraformaldehyde-fixed cryosections exhibited marked
structural changes in the kidneys of b/b rats (Fig. 3 B
and D) compared to those from /b animals (Fig. 3 A
and C). These were of various degrees and consisted of
an enhanced granularity of the tubular epithelium in
the kidney cortex, and in an ill-defined corticomedullary
junction, with projections of the medullary collecting
epithelium and of the stromal component into the cortex
of b/b rats (Fig. 3B). Dilated channels were also visible
just above the corticomedullary junction in the kidneys
of b/b animals. Due to the lack of lining tubular epithe-
lium, erythrocytes, and lymphocytes, these are likely to
Fig. 4. DMT1 mRNA expression in b/b rats. Medium stringency north-
ern analysis of rat kidney total RNA (10 g/lane) using 1.5 kb DMT1
probe. Analysis was performed using 15 g of total RNA from /b
and b/b rat kidneys (N  4 for each group) and from the duodenum
of /b and b/b animals (positive controls). RNA was electrophoresed,
transferred onto membrane, hybridized at high stringency to a 32P-
labeled DNA probe common for iron response element (IRE) and non-
IRE (NIRE) isoforms of rat DMT1 (nucleotides 85-1600 of rat DMT1)
recognizing transcripts at 4.4, 4, and 2.4 kb. Molecular weight markers
(kb) are shown at the left-hand side of the figure. After detection,
membranes were stripped and equivalency of loading was confirmed
by using a housekeeping rat	-actin probe. IRE is iron response element.
be of lymphatic nature. At higher magnification, b/b rats
exhibit enhanced granularity in the tubular epithelium.
In one out of four rats this hypergranularity resulted in
an almost complete occlusion of the lumina of the tubules
(not shown). Glomeruli of b/b rats showed increased
cellularity without fibrosis or sclerosis (Fig. 3D) or irreg-
ularity in the capillary loops. These changes were not
observed in kidneys from /b rats (Fig. 3C), although
occasionally dilated spaces were still present in some,
but not all, the kidneys from /b animals (not shown).
No iron deposits were found in the kidneys of /b
and b/b rats due to the dietary iron supplementation
over the term of the experiment (not shown).
Molecular observations
Expression of DMT1 mRNA in b/b rats. We have
previously shown that high stringency Northern analysis
using rat kidney mRNA probed with a probe common
to both IRE and NIRE isoforms of DMT1 detected
transcripts of 4.4, 4.0, and 2.4 kb [17]. Current experi-
ments on equally loaded, 	-actin–positive total RNA
samples from /b and b/b rat kidneys indicate low ex-
pression levels of identical transcript sizes in all samples,
and that the overall DMT1 mRNA expression is un-
changed in the kidneys of /b and b/b animals (Fig. 4,
left panel). In contrast, as previously reported for the
G185R mutation in rat [18], DMT1 mRNA is up-regu-
lated in the proximal duodenum of b/b rats (Fig. 4, right
panel). The same figure also shows that, in agreement
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Fig. 5. Semiquantitative immunoblotting DMT1 immunoreactivity in
the kidneys of b/b rats. A total of 30 g crude membrane extracts of
whole kidneys were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) on an 8% polyacrylamide gel,
blotted onto nitrocellulose membrane, and hybridized with a rabbit
amino-terminus antibody against rat DMT1 sequence. The antibody
was raised in rabbit against a peptide sequence (amino acid 1-21) of
the putative rat DMT1, which is identical in both iron response element
(IRE) and non-IRE (NIRE) isoforms, and was affinity purified as de-
scribed elsewhere prior to use [14]. DMT1 immunoreactivity of crude
membrane extracts from whole kidneys from/b and b/b rats (represen-
tative of four for each group). The DMT1 antiserum recognizes a dou-
blet of approximately 61 to 63 kD in kidney extracts from /b animals,
which is strongly reduced in kidney extracts from b/b animals. Equal
loading onto the gel was confirmed by Coomassie staining. Molecular
mass markers (kD) are shown on the left of each panel. IRE is iron
response element.
Fig. 6. Immunolocalization of DMT1 protein in the kidneys of anemic
b/b rats. Micrographs taken using identical exposure time of indirect
immunofluorescence using an affinity-purified antiserum is directed
against the amino terminus of rat DMT1. 4 m-thick cryosections ob-
tained from paraformaldehyde-fixed kidneys of /b (A ) and b/b rats
(B ). DMT1 immunoreactivity is highly present in the kidney of /b
rats with the exception of glomeruli, while it is negligible in b/b rats.
Magnification 85.
with previous studies [18], DMT1-related transcripts are
unchanged in the duodenum of /b animals.
Expression of DMT1 protein in b/b rats. To test the
effect of the G185R mutation on rat renal DMT1 protein
expression, we employed semiquantitative immunoblot-
ting with an anti-DMT1–affinity-purified polyclonal anti-
body [17] and compared the DMT1 content in kidneys
from /b and b/b rats. By this method, we determined
that the whole kidney content of DMT1 is significantly
reduced from 39.0  7.8 (OD/mm2, arbitrary units) in
the /b rats to 10.02  2.9 (N  4, P 
 0.05) (Fig. 5).
No signal was detected in rat kidney membranes from
both/b and b/b animals when the anti-DMT1 antibody
was preabsorbed by the antigenic peptide (not shown).
Low magnification images of immunofluorescence mi-
croscopy on rat kidney cryosections from /b and b/b
rats showed a markedly reduced expression in DMT1
staining throughout the kidneys of the b/b rat (Fig. 6B)
Fig. 7. Effect of the G185R mutation in the kidney of the anemic
Belgrade rat. Micrographs of DMT1 immunofluorescence in superficial
cortex (A and B ) and outer medulla (C and D ) of Belgrade heterozygote
(/b ) (A and C), and b/b rat (B and D). The antibody used recognizes
both iron response elements (IRE) and non-IRE (NIRE) isoforms of
DMT1. (A) In/b rats, DMT1 immunofluorescence is strongly present
in the renal parenchyma with predominant intracellular distribution in
proximal tubules (arrowheads) and apical and intracellular immuno-
staining in the cortical collecting ducts (arrows). (B) DMT1-specific
staining is almost absent in the cortex of Belgrade rats. (A and B)
magnification 170. (C and D) S3 segments of Belgrade heterozygote
(/b ) (C) and b/b rat (D). S3 segments of b/b rats demonstrate a
substantial reduction in DMT1 immunofluorescence. (C and D magnifi-
cation 340). IRE is iron response element.
compared to/b rats (Fig. 6A). At higher magnification,
the reduction in DMT1 immunostaining in b/b rats seems
to be due to a decrease in both the intensity of the
immunoreactivity and in the number of cells expressing
the transporter (Fig. 7). Figures 7A and B show that the
reduction did not appear to be region-specific, as it could
also be observed in proximal tubule, collecting duct and
distal convoluted tubule cells (arrow and arrowheads,
respectively). Occasionally, residual staining was de-
tected intracellularly in S3 segments of the proximal tu-
bules (Fig. 7D). Serial sections from /b (Fig. 8A and
B) and b/b rats (Fig. 8C and D) show that expression
of AQP1, a marker for proximal tubule, is comparable
between the two experimental groups (Fig. 8B and D),
indicating that the reduction of DMT1 immunofluores-
cence in b/b rats (Fig. 8C) compared to /b (Fig. 8A) is
not a result of alterations in proximal tubule morphology.
Although not shown, similar results were obtained when
serial sections from /b and b/b rats were immuno-
stained for DMT1 and AQP2, a marker for collecting
ducts. Identical results were observed using different
types of fluorophores and fixation protocols (i.e., PLP
fixative, not shown) and no signal was detected in slides
in which the primary antibody was preabsorbed with
the antigenic peptide and in slides in which the primary
antibody was omitted (not shown).
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Fig. 8. The expression of aquaporin 1, a marker for proximal tubule,
is unchanged in the kidneys of the anemic Belgrade rat. DMT1 (A and
C ) and aquaporin-2 (AQP1) (B and D ) immunoreactivities in 4 m
thick sections from paraformaldehyde-fixed rat kidneys. (A and B)
Serial sections from /b rat (representative of three experiments). (C
and D) Serial sections from b/b rats. AQP1 distribution pattern in /
b rats (B) is comparable to that of b/b animals (D) indicating that the
reduction of DMT1 immunofluorescence in b/b (C) compared to /b
(A) rats is not a result of alterations in proximal tubule morphology.
Magnification 170.
DISCUSSION
Belgrade rats have severe anemia, which negatively
affects body weight, survival to adulthood, hematologic
parameters and reproduction [4]. The lack of tissue iron
and the elevated total iron binding capacity in b/b ani-
mals indicates that the body “iron stat” detects an iron
deficiency even though serum iron levels are elevated.
In the duodenum of b/b rats [18] and in that of the
murine model, the mk/mk mice [13], there is a dramatic
up-regulation in the expression of the mutant DMT1
mRNA and protein, respectively, in response to iron
deficiency, most likely mediated by a feedback regula-
tory mechanism sensing the levels of body iron in the
stores. In contrast, DMT1 expression in the kidneys of
mk/mk mice is strongly reduced [14], indicating differen-
tial regulation of the transporter at the two sites. The
purpose of this study was to examine the consequences
of loss of functional DMT1 protein on ion handling, on
morphologic changes, and on the expression levels of
DMT1 in the kidneys of b/b rats. First, to test for the
consequences of the defective allele in the /b vs. b/b
phenotype, we assessed urinary and serum levels of dif-
ferent electrolytes in /b and b/b animals. Garrick et al
[4] have shown that dietary iron supplements improve
red blood cell count with little effect on the quality of
the microcytic, hypochromic cells leaving the apparent
underlying defect unaffected. To ensure that any changes
seen were due to an effect of the G185R mutation rather
than to the underlying anemia, all our observations were
made on animals kept on an iron-supplemented diet.
We observed that serum iron levels were significantly
elevated in Belgrade rats, consistent with previous obser-
vations by Garrick et al [4] and Sladic-Simic [6]. This is
due to the diminished ability of the tissue to utilize iron
[4]; this inability in turn is due to the failure of iron to
leave the endosomal compartment [2, 10]. Despite the
increased serum iron levels, urinary excretion of iron
was comparable between /b and b/b rats. Thus, if we
assume that b/b rats filter more iron given the increased
serum iron levels, then we must conclude that b/b rats
reabsorb more iron. Given that b/b rats show iron defi-
ciency in many tissues due to the G185R mutation in
DMT1, this would be consistent with a stimulation of
iron transport, through the stores (and possibly through
the erythroid) regulator (see [23] for review).
Food intake was significantly increased in b/b rats,
possibly as a consequence of the necessity to increase
dietary iron intake. Fecal excretion of iron was also en-
hanced in b/b vs. /b animals. Since the ratio between
fecal output and food intake is 58% for b/b animals
and 51% for /b rats, we believe that the increased
fecal iron output in b/b rats could be due to both a
reduced intestinal iron absorption, as documented by
Oates et al [18], and/or to a direct consequence of the
increased dietary iron intake.
Urine volume and osmolar output were not significantly
different in /b and b/b animals and, with the exception
of Ca2, urine outputs of ions were also comparable
between the two experimental groups. Given that DMT1
is not known to transport calcium or magnesium [21],
this dramatic increase in urinary calcium excretion result
is somewhat surprising. Interestingly, urinary Mg2 ex-
cretion levels were not significantly different between the
two experimental groups. Since calcium and magnesium
reabsorption by the kidney proceed in parallel and can
only be discriminated at the level of the distal convoluted
tubule, and since in these experiments the hypercalciuria
is not accompanied by hypermagnesiuria, our observa-
tions indicate that b/b rats could have a distal tubular
defect. Clearly, the effects of the G185R mutation on the
expression of proteins involved in the transcellular trans-
port of calcium [Ca-adenosine triphosphatase (ATPase),
Na/Ca exchanger, calbindins, calcium-sensing receptor,
calcium transporters, and thiazide-sensitive Na-Cl co-
transporter) and regulating paracellular magnesium per-
meability (paracellins) has to be evaluated.
Histologic characterization of the b/b phenotype indi-
cates an enhanced hypergranularity in the tubular epithe-
lium and increased cellularity compared to /b rats. In
the reticulocytes of Belgrade rats, iron movement from
the endosome to the mitochondria is severely impaired
[2, 7, 24]. Thus, the lack of DMT1 in the intracellular
compartments of proximal tubular cells could also affect
intracellular organelles’ function. It will be interesting
to compare functional and ultrastructural features of the
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endosomal/mitochondrial compartments of the kidneys
of b/b rats. Whatever the nature of the damage, it does
not affect the expression of protein markers for the prox-
imal tubule and collecting duct, AQP1 and AQP2, re-
spectively (see below).
Northern analysis using total RNA samples extracted
from both renal and duodenal tissue from /b and b/b
rats probed with a DMT1 probe shows comparable
DMT1 mRNA abundance in the kidneys of /b and b/b
animals while there is considerable variation in DMT1
transcripts in the duodenum of /b and b/b rats. In
contrast, we observed a consistent and reproducible up-
regulation in DMT1 mRNA in duodenal samples from
the same animals under the same experimental condi-
tions. This is in agreement with previous findings in the
rat duodenum [18], where DMT1 mRNA levels are en-
hanced in b/b but not in /b rats, and indicates that
the differences between DMT1 mRNA distribution in
kidney versus duodenum are due to different regulation
in the two different tissues and not due to different exper-
imental conditions.
Analysis of renal protein distribution and expression
indicate the almost complete lack of DMT1 protein in
the G185R mutant compared to /b. This is in line with
observations made by Canonne-Hergaux and Gros [14],
who have estimated a 6- to 50-fold decrease in DMT1
immunoreactivity in kidney membranes from mk/mk
mice [14]. These results suggest that the mutation causes
either defective posttranslational processing of the pro-
tein, leading to an absence of cell surface and endosomal
expression, or to accelerated protein degradation. If one
of these hypotheses is true, this indicates that in the
kidney the genetic abnormality affects the stability
and/or maturation of the mutant protein, which would
lead to the virtual absence of the normal carrier. In
vitro studies performed using transient expression of the
G185R mutant in HEK293 cells [12] show that both
the wild-type and mutated DMT1 protein have similar
cellular localization (i.e., to the transferrin-positive recy-
cling endosomes), and that G185R mutation is function-
ally deleterious. Iron accumulation in transfected cells
is severely reduced (35-fold). The mutation results in
decreased DMT1 expression on the cell surface. Biotinyl-
ation experiments demonstrate that both wild-type and
G185R are at the plasma membrane but G185R is 4- to
10-fold less (i.e., decreased levels of mutant protein ap-
pear to contribute, but cannot fully explain the loss of
function) [12]. In the duodenum of b/b rats, the absorp-
tive defect lies in the uptake phase of transport across the
microvillous membrane, it is not due to an abnormality of
an iron-reductive mechanism [25, 26] while the G185R
mutant appears to interfere with proper targeting to the
brush border of the duodenal epithelium in vivo. The
loss of function of DMT1 is caused by a combination of
increased degradation and defective iron transport by
the residual protein rather than by diminished transcrip-
tion because the amount and site of DMT1 mRNA ex-
pression were similar in b/b rats fed a normal diet and
iron-deficient Wistar rats [8]. In the duodenum of mk/mk
mice, loss of DMT1 function is accompanied by an in-
crease in the expression of the defective mRNA and
protein species [13]. Similarly to the rat duodenum, in the
mouse, the G185R mutation also affects the membrane
targeting of the protein in mk/mk enterocytes [27] and
kidney cells [14], indicating that the effects of the G185R
mutation is tissue-specific. What could be the explana-
tion for this discrepancy? In duodenal crypt cells of b/b
rats and mk/mk mice, the level of intracellular iron de-
creases, reflecting the change in body iron status. As a
consequence, gastrointestinal iron uptake is increased,
most likely by a feedback regulatory mechanism sensing
the levels of body iron in the stores [18]. Canonne-Her-
gaux et al [13] have speculated that this could induce an
increased DMT1 mRNA stability and translation rate
through binding of iron-response proteins (IRPs) to the
IREs located in the 3 UTR of isoform 1 of DMT1. The
hypothesis of an alternative expression of IRPs in the
kidney and the duodenum needs to be tested. The G185R
mutation in DMT1 in the kidney is reminiscent of the
mutation in the gene for natural resistance to intracellu-
lar infection (Nramp1), which is molecularly similar to
DMT1. The G169D mutation in Nramp1 corresponds to
the glycine residue immediately adjacent to the G185R
mutation in DMT1 and impairs mouse resistance to in-
fection with intracellular parasites. In both circumstances
the mutations affect normal processing of the protein,
with possible targeting for degradation [28].
CONCLUSION
Our study has demonstrated that the G185R mutant
results in the absence of mature DMT1 protein in the
kidneys of b/b rats. Whatever the mechanism, it is clear
that, despite the almost complete lack of DMT1 protein
in b/b rats, these animals excrete iron at the same rate
as /b animals. Since the rat kidney reabsorbs 90%
of the filtered iron [16], our results indicate that DMT1
does not appear to play a crucial role in iron reabsorption
by the kidney. However, the significant hypercalciuria
without hypermagnesiuria in b/b rats suggests distal tu-
bular impairment. This is consistent with our previous
functional and localization studies, which indicated that
in the rat kidney DMT1 is expressed and functional at
the luminal membrane in the distal nephron [16, 17].
Since proximal tubular iron transport occurs through a
mechanism, which differs from DMT1 and reabsorption
of iron by the distal nephron only accounts for 6% of
the total iron reabsorption [abstract; Wareing et al, J Am
Soc Nephrol 12:43A, 2001), an additional, unidentified
mechanism must be responsible for most of the iron
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reabsorption by the proximal tubule. Moreover, we can-
not rule out the possible role of other proteins involved
in the regulation of renal iron reabsorption in the b/b
rats, such as ferrireductase and/or ferroportin (i.e., Ireg1,
MTP, Slc11A3) [29–32] on the basolateral membrane
that could be rate-limiting in iron acquisition.
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